gene_symbol
CD19
hgnc_id
HGNC:1633
binding_type
antigen recognition
cytotoxicity
YES
cytotoxicity_type
DIRECT
cytotoxicity_mechanism
Blinatumomab bridges CD19 on target cells to CD3 on T cells, forming an immunologic synapse; activated T cells kill CD19+ cells via perforin/granzyme-mediated cytolysis (MHC-independent).
enzyme_product
Off
epitope
Off
variant
Off
isoform
Off
hla_specific
Off
gated
Off
other_modifier
B-lineage cell surface antigen on leukemia cells
trial_id_tar_ref
drug_id_tar_ref
disease_id_tar_ref
nct_id_tar_ref
NCT06658938
disease_id_num_tar_ref
5014
drug_id_num_tar_ref
13548